Haw Par Corporation Limited
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases… Read more
Haw Par Corporation Limited - Asset Resilience Ratio
Haw Par Corporation Limited (HAWPF) has an Asset Resilience Ratio of 77.29% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2024)
This chart shows how Haw Par Corporation Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Haw Par Corporation Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $3.25 Billion | 77.29% |
| Total Liquid Assets | $3.25 Billion | 77.29% |
Asset Resilience Insights
- Very High Liquidity: Haw Par Corporation Limited maintains exceptional liquid asset reserves at 77.29% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Haw Par Corporation Limited Industry Peers by Asset Resilience Ratio
Compare Haw Par Corporation Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367 |
Drug Manufacturers - General | 32.14% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
Drug Manufacturers - General | 0.00% |
|
PharmGen Science Inc
KO:004720 |
Drug Manufacturers - General | 0.16% |
Annual Asset Resilience Ratio for Haw Par Corporation Limited (2001–2024)
The table below shows the annual Asset Resilience Ratio data for Haw Par Corporation Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 74.54% | $3.19 Billion | $4.28 Billion | +1.18pp |
| 2023-12-31 | 73.36% | $2.64 Billion | $3.59 Billion | -4.56pp |
| 2022-12-31 | 77.92% | $2.84 Billion | $3.65 Billion | +0.93pp |
| 2021-12-31 | 76.99% | $2.53 Billion | $3.28 Billion | +0.61pp |
| 2020-12-31 | 76.38% | $2.25 Billion | $2.95 Billion | -4.51pp |
| 2019-12-31 | 80.89% | $2.62 Billion | $3.24 Billion | +64.58pp |
| 2018-12-31 | 16.31% | $494.17 Million | $3.03 Billion | +4.98pp |
| 2017-12-31 | 11.33% | $369.87 Million | $3.26 Billion | -14.64pp |
| 2016-12-31 | 25.97% | $684.62 Million | $2.64 Billion | +1.05pp |
| 2015-12-31 | 24.92% | $670.86 Million | $2.69 Billion | +9.15pp |
| 2014-12-31 | 15.76% | $468.83 Million | $2.97 Billion | +0.28pp |
| 2013-12-31 | 15.48% | $397.20 Million | $2.57 Billion | -0.12pp |
| 2012-12-31 | 15.60% | $369.83 Million | $2.37 Billion | -4.50pp |
| 2011-12-31 | 20.10% | $377.11 Million | $1.88 Billion | +3.69pp |
| 2010-12-31 | 16.41% | $335.08 Million | $2.04 Billion | -2.55pp |
| 2009-12-31 | 18.95% | $379.71 Million | $2.00 Billion | +1.22pp |
| 2007-12-31 | 17.74% | $361.43 Million | $2.04 Billion | -1.02pp |
| 2006-12-31 | 18.75% | $356.45 Million | $1.90 Billion | -0.35pp |
| 2005-12-31 | 19.10% | $266.59 Million | $1.40 Billion | +6.05pp |
| 2004-12-31 | 13.05% | $83.77 Million | $641.72 Million | -1.67pp |
| 2003-12-31 | 14.72% | $102.96 Million | $699.50 Million | -0.53pp |
| 2002-12-31 | 15.25% | $116.54 Million | $764.18 Million | -2.31pp |
| 2001-12-31 | 17.56% | $143.73 Million | $818.31 Million | -- |